WuXi AppTec reports 5% revenue growth in 2024, excluding Covid-19 projects, announces dividends, and proposes buyback plan. Expects 10–15% growth in 2025 with total revenue target of RMB41.5–43.0B.
What is covered in the Full Insight:
Introduction to WuXi AppTec's 2024 Performance
Financial Highlights and Segment Analysis
Order Backlog and Client Growth
Capacity Expansion Plans
Conclusion and Market Comparison
Boomeranged on Tue, 29 Apr 2025 13:48
1Q25 resumes double-digit growth, with revenue growing 21% YoY and net profit increasing 40% YoY. Growth was driven by Wuxi Chemistry segment. U.S. revenue is up 28%. Gross profit margin is back to normal level (41.9%). Backlog is up 47% YoY (added RMB 3B during 1Q25). Reiterated 2025 revenue growth guidance of 10–15% YoY. No mention of tariff impact. Continue to hold.
SUMMARY
(Sign Up to Access)
Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
Unlock research summaries
Follow top, independent analysts
Receive personalised alerts
Access Analytics, Events and more
Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.